Q2 2026 Holdings
Filed 2026-08-14 | 85 holdings | $580.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $38.2M | 1,223,019 | 6.6% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $37.8M | 283,657 | 6.5% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $30.0M | 159,943 | 5.2% |
| Erasca Inc(ERAS) | COM | 29479A108 | $28.7M | 1,565,913 | 4.9% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $20.2M | 632,754 | 3.5% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $19.6M | 200,851 | 3.4% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $17.6M | 346,914 | 3.0% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $16.3M | 602,686 | 2.8% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $15.8M | 1,064,200 | 2.7% |
| Surrozen Inc(SRZN) | COM NEW | 86889P208 | $13.8M | 602,798 | 2.4% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $13.4M | 209,234 | 2.3% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $13.2M | 239,146 | 2.3% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $13.0M | 248,015 | 2.2% |
| First Tracks Biotherapeutics(TRAX) | ORD SHS | 337185102 | $12.5M | 622,723 | 2.2% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $12.5M | 37,243 | 2.1% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $12.3M | 348,408 | 2.1% |
| Bioage Labs Inc(BIOA) | COM | 09077V100 | $11.4M | 464,171 | 2.0% |
| CG Oncology Inc(CGON) | COM | 156944100 | $11.3M | 159,349 | 2.0% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $11.1M | 116,461 | 1.9% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $10.7M | 276,527 | 1.8% |
| Celcuity Inc(CELC) | COM | 15102K100 | $10.3M | 98,203 | 1.8% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $10.1M | 1,460,093 | 1.7% |
| Climb BIO Inc(CLYM) | COM | 28658R106 | $9.7M | 742,745 | 1.7% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $9.5M | 106,926 | 1.6% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $8.1M | 1,368,215 | 1.4% |
| Inflarx NV(IFRX) | COM | N44821101 | $7.2M | 3,228,255 | 1.2% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $6.9M | 384,304 | 1.2% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $6.6M | 178,412 | 1.1% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $6.5M | 2,417,283 | 1.1% |
| Equillium Inc(EQ) | COM | 29446K106 | $6.5M | 2,016,607 | 1.1% |
| Definium Therapeutics Inc(DFTX) | COM SHS | 24477V105 | $6.5M | 137,124 | 1.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $6.4M | 75,603 | 1.1% |
| Damora Therapeutics Inc(GLTO) | COM NEW | 36322Q206 | $5.6M | 216,194 | 1.0% |
| Inventiva SA(IVA) | ADS | 46124U107 | $5.4M | 1,426,320 | 0.9% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $5.3M | 2,146,182 | 0.9% |
| Aura Biosciences Inc(AURA) | COM | 05153U107 | $5.1M | 714,280 | 0.9% |
| Eyepoint Inc(EYPT) | COM NEW | 30233G209 | $4.8M | 338,471 | 0.8% |
| Assembly Biosciences Inc(ASMB) | COM NEW | 045396207 | $4.7M | 170,378 | 0.8% |
| Whitehawk Therapeutics Inc(WHWK) | COM | 00032Q104 | $4.7M | 1,021,037 | 0.8% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $4.6M | 76,075 | 0.8% |
| Uniqure NV(QURE) | SHS | N90064101 | $4.1M | 88,115 | 0.7% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $4.0M | 284,769 | 0.7% |
| Avalyn Pharmaceuticals Inc(AVLN) | COM SHS | 05348Y105 | $3.9M | 118,000 | 0.7% |
| Maplight Therapeutics Inc(MPLT) | COM | 56565P103 | $3.8M | 106,906 | 0.7% |
| Alumis Inc(ALMS) | COM | 022307102 | $3.8M | 135,736 | 0.7% |
| Axsome Therapeutics Inc.(AXSM) | COM | 05464T104 | $3.8M | 15,375 | 0.6% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $3.7M | 153,544 | 0.6% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $3.6M | 143,167 | 0.6% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $3.6M | 358,780 | 0.6% |
| Personalis Inc(PSNL) | COM | 71535D106 | $3.3M | 247,783 | 0.6% |